|
Corporate strategy and development of a mature biotech company
Situation
- Clinical-stage biopharmaceutical company with innovative therapies for immuno-sensitive cancers
- After a significant financing round, the company wanted to strengthen its business development activities and accelerate
Bionest Contribution
- Bionest organized a 2-day workshop with company’s board to develop a comprehensive corporate development plan
- Bionest performed surrogate business development activities, before subsequent handover to a full-time manager
Key Results
- The company benefited from :
- A strong and detailed business development roadmap
- A significant increase in level of business development activities
- The company was then well equipped to sign attractive collaboration agreement


|